author-photo

Dragana Milojkovic

Imperial College London
Imperial College Healthcare
Hammersmith Hospital

227

Papers

6575

Citations

Citation Trend

Filter By

Papers (165) Sort By

Journal Conference Others

Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Multi-Arm Trial of Inflammatory Signal Inhibitors (MATIS) for Hospitalised Patients with Mild or Moderate COVID-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomised Controlled Trial

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation.

2021 Frontiers in Cellular and Infection Microbiology
Show All
- Source
- Cite
- Save
Citations (1)
Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for Hospitalised Patients with Mild or Moderate COVID-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomised Controlled Trial

2021
Show All
- Source
- Cite
- Save
Citations (2)
The role of ibrutinib in COVID-19 hyperinflammation: a case report.

2021 International Journal of Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (2)
Ponatinib in Combination with FLAG-IDA Chemotherapy for Blast-Phase Chronic Myeloid Leukemia: Final Results of the Seamless Phase I/II Dose-Finding UK Trials Acceleration Programme (TAP) Matchpoint Trial

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Lymphoid blast crisis after prolonged treatment‐free remission in chronic myeloid leukaemia after tyrosine kinase inhibitor de‐escalation during the COVID‐19 pandemic

2021
Show All
- Source
- Cite
- Save
Citations (0)
Outcomes before and after dose reduction in patients with newly diagnosed chronic myeloid leukemia receiving bosutinib or imatinib.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
COVID-19 in Patients with Chronic Myeloid Leukemia: Poor Outcomes for Patients with Comorbidities, Older Age, Advanced Phase Disease, and Those from Low-Income Countries: An Update of the Candid Study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study.

2020 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (4)